Wealth Enhancement Advisory Services, LLC Oramed Pharmaceuticals Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 18,799 shares of ORMP stock, worth $39,477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,799
Previous 13,799
36.23%
Holding current value
$39,477
Previous $29,000
44.83%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ORMP
# of Institutions
62Shares Held
8.22MCall Options Held
11.2KPut Options Held
200-
Bml Capital Management, LLC Zionsville, IN3.02MShares$6.34 Million5.23% of portfolio
-
Murchinson Ltd. Toronto, A61.75MShares$3.68 Million0.46% of portfolio
-
Boothbay Fund Management, LLC New York, NY845KShares$1.78 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$769,4422.07% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY252KShares$529,6700.61% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $81.5M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...